Westfield Capital Management CO LP Rocket Pharmaceuticals, Inc. Transaction History
Westfield Capital Management CO LP
- $21.2 Billion
- Q3 2024
A detailed history of Westfield Capital Management CO LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Westfield Capital Management CO LP holds 4,493,833 shares of RCKT stock, worth $58.6 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
4,493,833
Previous 4,327,922
3.83%
Holding current value
$58.6 Million
Previous $93.2 Million
10.92%
% of portfolio
0.39%
Previous 0.47%
Shares
24 transactions
Others Institutions Holding RCKT
# of Institutions
209Shares Held
93.2MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$231 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$147 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$80.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$72.2 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.12MShares$53.7 Million1.58% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $987M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...